A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis
Phase of Trial: Phase IV
Latest Information Update: 11 Jul 2019
Price : $35 *
At a glance
- Drugs Crisaborole (Primary)
- Indications Seborrhoeic dermatitis
- Focus Proof of concept; Therapeutic Use
- 09 Jul 2019 Planned End Date changed from 1 Aug 2019 to 1 Sep 2020.
- 09 Jul 2019 Planned primary completion date changed from 1 Jun 2019 to 1 May 2020.
- 04 Dec 2018 Status changed from not yet recruiting to recruiting.